This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s …
In a research report issued today, Oppenheimer analyst Michael Wiederhorn maintained a Perform rating on Aetna (NYSE:AET). No price target was provided.
